#AIEye #Podcast 505: GBT Tokenize (OTCPINK: $GTCH) Researching #AI Detection System and Datametrex (TSXV: $DM.V) to Acquire 100% of Concierge Medical Consultants; #artificialintelligence
Global
Intelligent Drug Discovery Market to Reach $3.71 Billion by 2027
Point Roberts WA, Vancouver BC – January 7, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2021/010721-AI-Eye.mp3
Read
this in full at https://www.investorideas.com/news/2021/artificial-intelligence/01071GTCH-Datametrex.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (OTCPINK:GTCH) (TSXV:DM)
GBT Tokenize Corp, the joint venture of GBT Technologies
Inc. (OTC PINK:GTCH), is continuing research on an AI system to detect and
open clogs within arteries based on its proprietary radio technology, which has
an internal code name of "Hermes". Danny Rittman, GBT’s CTO,
explained:
"Our
AI technology can be implemented in a wide variety of applications to control
mechanical, optical and electrical systems, analyzing arterial data and making
decisions in real time. We are commencing research - code name Hermes, to use
our AI capabilities to search, identify and remove plaque within arteries and
blood vessels. In this project, we are researching the ability to use GBT
Tokenize's AI technology to control a mini-probe unit that will be inserted
into a human body through a main artery. If our research is positively
concluded, we believe that this type of system can be a breakthrough within the
cardiovascular domain, offering less invasive treatments and introducing a new
method to save lives. Artificial Intelligence technology encapsulates the
future health care and we're investing vast efforts to utilize our experience
and knowledge in this domain."
Datametrex AI Limited (TSXV:DM) has entered into a binding Letter of Intent to
acquire 100 percent of Concierge Medical Consultants Inc., described in the
press release as “an arm's length private telehealth and medical concierge
services company.” Datametrex CEO Marshall Gunter said:
"The
significance of the acquisition of this medical business cannot be understated.
The demand for telehealth and concierge medical service is expected to continue
to strengthen as the market for remote healthcare grows. We look forward to
working with Dr. Sharif (founder and CEO of Concierge Medical Consultants) and
his medical team to grow this business under Datametrex."
Global
Intelligent Drug Discovery Market to Reach $3.71 Billion by 2027
A report published by Emergen Research finds that the global
Intelligent Drug Discovery market will grow from $258.9 million in 2019 to
$3.71 billion by 2027 with a compound annual growth rate (CAGR) of 39.4 percent
in the forecast period. An excerpt from the report synopsis outlines the role
of AI in the market:
Artificial
intelligence is commonly used in the development of novel drugs. The market
manufacturers are investing in partnerships and collaborations to drive the
demand for technology. It reduces time as well as the overall cost of the drug
development procedure, which makes it attractive among pharmaceutical
companies. The dearth of a skilled professional and lack of data sets are
hindering its growth. Furthermore, increasing awareness of the integration of
AI in the healthcare industry will offer growth opportunities to the market.
Sam Mowers, Investorideas.com
Read and hear
other editions of the AI Eye
For a list of
artificial intelligence stocks on Investorideas.com visit here
Investors can
trade these stocks and other ideas on
our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
About
GBT Technologies Inc.
GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com)
is a development-stage company which considers itself a native IoT creator,
developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled
mobile technology platforms. GBT has a
portfolio of Intellectual Property that, when commercialized, will include
smart microchips, mobile and security applications and protocols, and
supporting cloud software. GBT’s system
envisions the creation of a global mesh network. The core of the system will be its advanced
microchip technology that can be installed in any mobile or fixed device
worldwide. GBT envisions this system as a low-cost, secure, private mesh
network between any enabled devices, providing shared processing, advanced
mobile database management/sharing and enhanced mobile features as an
alternative to traditional carrier services.
About Investorideas.com - News that Inspires Big
Investing Ideas Investorideas.com is a recognized news source publishing third party
news, research and original financial content. Learn about investing in stocks
and sector trends with our news alerts, articles, podcasts and videos,
looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts Cannabis News
and Stocks on the Move podcast and column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
The
Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com,
iHeartRadio and Google Play Music.
Visit the Podcast
page at Investorideas.com:
https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Disclosure: GTCH is a paid
monthly ai stock on investor ideas
Global investors must
adhere to regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye-
Watching stock news, deal tracker and advancements in artificial
intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800 665 0411
Get more Technology stock investor
ideas - news, articles, podcasts and stock directories
No comments:
Post a Comment